You are here

Home

Biblio

[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Blue EE, Cheng A, Chen S, Yu C-E.  2020.  Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.. JAMA Netw Open. 3(10):e2017666.
Blue EE, Yu C-E, Thornton TA, Chapman NH, Kernfeld E, Jiang N, Shively KM, Buckingham KJ, Marvin CT, Bamshad MJ et al..  2018.  Variants regulating ZBTB4 are associated with age-at-onset of Alzheimer's disease.. Genes Brain Behav. 17(6):e12429.
Blue EE, Horimoto ARVR, Mukherjee S, Wijsman EM, Thornton TA.  2019.  Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics.. Alzheimers Dement. 15(12):1524-1532.
Blue EE, Thornton TA, Kooperberg C, Liu S, Wactawski-Wende J, Manson JA, Kuller L, Hayden K, Reiner AP.  2021.  Non-coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in women.. Alzheimers Dement. 17(2):215-225.
Braggin JE, Bucks SA, Course MM, Smith CL, Sopher B, Osnis L, Shuey KD, Domoto-Reilly K, Caso C, Kinoshita C et al..  2019.  Alternative splicing in a presenilin 2 variant associated with Alzheimer disease.. Ann Clin Transl Neurol. 6(4):762-777.
Bressler J, Marioni RE, Walker RM, Xia R, Gottesman RF, B Windham G, Grove ML, Guan W, Pankow JS, Evans KL et al..  2019.  Epigenetic Age Acceleration and Cognitive Function in African-American Adults in Midlife: The Atherosclerosis Risk in Communities Study.. J Gerontol A Biol Sci Med Sci.
Breuza L, Arighi CN, Argoud-Puy G, Casals-Casas C, Estreicher A, Famiglietti MLivia, Georghiou G, Gos A, Gruaz-Gumowski N, Hinz U et al..  2020.  A Coordinated Approach by Public Domain Bioinformatics Resources to Aid the Fight Against Alzheimer's Disease Through Expert Curation of Key Protein Targets.. J Alzheimers Dis. 77(1):257-273.
Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes-Dumeyer D, Lantigua RA, Lao PJ, Stern Y, Vonsattel JPaul, Teich AF et al..  2021.  Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.. Alzheimers Dement. 17(8):1353-1364.
Broce IJ, Tan CHong, Fan CChieh, Jansen I, Savage JE, Witoelar A, Wen N, Hess CP, Dillon WP, Glastonbury CM et al..  2019.  Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease.. Acta Neuropathol. 137(2):209-226.
Bush WS, Wheeler N, Beaulieu-Jones B, Darabos C.  2020.  Packaging Biocomputing Software to Maximize Distribution and Reuse.. Pac Symp Biocomput. 25:739-742.
Bussies PL, Rajabli F, Griswold A, Dorfsman DA, Whitehead P, Adams LD, Mena PR, Cuccaro M, Haines JL, Byrd GS et al..  2020.  Use of local genetic ancestry to assess -523' and risk for Alzheimer disease.. Neurol Genet. 6(2):e404.
Butkiewicz M, Blue EE, Leung YYee, Jian X, Marcora E, Renton AE, Kuzma A, San Wang L-, Koboldt DC, Haines JL et al..  2018.  Functional annotation of genomic variants in studies of late-onset Alzheimer's disease.. Bioinformatics. 34(16):2724-2731.
Butkiewicz M, Haines JL, Bush WS.  2017.  Introducing COCOS: codon consequence scanner for annotating reading frame changes induced by stop-lost and frame shift variants.. Bioinformatics. 33(10):1561-1562.
C
Cali CP, Patino M, Tai YKit, Ho WYun, McLean CA, Morris CM, Seeley WW, Miller BL, Gaig C, Vonsattel JPaul G et al..  2019.  C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy.. Acta Neuropathol. 138(5):795-811.
Castillo-Barnes D, Su L, Ramírez J, Salas-Gonzalez D, Martinez-Murcia FJ, Illan IA, Segovia F, Ortiz A, Cruchaga C, Farlow MR et al..  2020.  Autosomal Dominantly Inherited Alzheimer Disease: Analysis of genetic subgroups by Machine Learning.. Inf Fusion. 58:153-167.
Chaudhury S, Brookes KJ, Patel T, Fallows A, Guetta-Baranes T, Turton JC, Guerreiro R, Bras J, Hardy J, Francis PT et al..  2019.  Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment.. Transl Psychiatry. 9(1):154.
Chauhan G, Adams HHH, Satizabal CL, Bis JC, Teumer A, Sargurupremraj M, Hofer E, Trompet S, Hilal S, Smith AVernon et al..  2019.  Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting.. Neurology.
Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J et al..  2021.  Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.. Nat Genet. 53(3):294-303.
Choi KYeong, Lee JJae, Gunasekaran TIniyan, Kang S, Lee W, Jeong J, Lim HJae, Zhang X, Zhu C, Won S-Y et al..  2019.  Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of ε4 on Alzheimer's Disease Risk in a Multiracial Sample.. J Clin Med. 8(8)
Cignarella F, Filipello F, Bollman B, Cantoni C, Locca A, Mikesell R, Manis M, Ibrahim A, Deng L, Benitez BA et al..  2020.  TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis.. Acta Neuropathol. 140(4):513-534.
Conner SC, Pase MP, Carneiro H, Raman MR, McKee AC, Alvarez VE, Walker JM, Satizabal CL, Himali JJ, Stein TD et al..  2019.  Mid-life and late-life vascular risk factor burden and neuropathology in old age.. Ann Clin Transl Neurol. 6(12):2403-2412.
Conner SC, Benayoun L, Himali JJ, Adams SL, Yang Q, DeCarli C, Blusztajn JK, Beiser A, Seshadri S, Delalle I.  2019.  Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.. J Alzheimers Dis. 68(1):357-365.
Crane PK, Foroud T, Montine TJ, Larson EB.  2017.  Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.. Alzheimers Dement. 13(12):1410-1413.
D
Damotte V, van der Lee SJ, Chouraki V, Grenier-Boley B, Simino J, Adams H, Tosto G, White C, Terzikhan N, Cruchaga C et al..  2021.  Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants.. Alzheimers Dement. 17(10):1663-1674.
Davis AA, Inman CE, Wargel ZM, Dube U, Freeberg BM, Galluppi A, Haines JN, Dhavale DD, Miller R, Choudhury FA et al..  2020.  APOE genotype regulates pathology and disease progression in synucleinopathy.. Sci Transl Med. 12(529)

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer